OCT 03, 2016 2:38 PM PDT

Investigation Finds 80% of Chinese Clinical Trial Data are Fraud

WRITTEN BY: Xuan Pham
A quality control survey of clinical trials in China has revealed gross misconduct in how the data for these trials were handled. The investigation alleges that more than 80 percent of data in these clinical trials were manipulated, doctored, and outright fabricated.

Chinese clinical trials lose credibility | Image: pixabay.com

Led by the Chinese State Food and Drug Administration (SFDA), the investigation reviewed data from over 1,600 clinical trials. These involved trials set to receive regulator approval for mass production. The expose was covered by the Economic Information Daily newspaper.

In the expose, SFDA found that more than 80 percent of the data showed scientific dishonesty and corruption at nearly every level. This included deletion of records for adverse events associated with treatments, and massaging data into desired outcomes.

More egregiously, the investigation found that the results of some clinical trials were concocted even before the study began.

This is a "breach of duty by supervision departments and malpractice by pharmaceutical companies, intermediary agents and medical staff," the State Food and Drug Administration (SFDA) said in its report, highlighting deliberate deceit at all levels. Even third party agencies such as contract research organizations whose jobs are to manage and inspect clinical trial facilities were found to be fraudulent and cited as “accomplices in data fabrication due to cutthroat competition and economic motivation.”

Clinical data fabrication is apparently a systemic problem that’s “an open secret even before the inspection,” said an unnamed source in the newspaper.
 


The problem may boil down to competition. And in a market where every pharmaceutical company is trying to earn approval to mass market a Western drug for profit, competition seems to have sabotaged scientific and ethical integrity.

"The domestic market for Western pharmaceuticals in China is either confined to very straightforward generic products that have been around for a long time ... or revolves around joint-venture pharmaceutical manufacture with foreign companies," said Luo Liang, a healthcare professional to Radio Free Asia.

"Either that, or Chinese pharmaceutical factories get hold of the formula for certain drugs whose patents have expired," said Luo Liang. "There are no new drugs in development in the same way that there are overseas."

To Liang and others, the degree of fraud in the Chinese clinical trials is wholly unsurprising and could potentially point to other aspects of Chinese science. "It's not just the medicines," said Mai Ke, a rights activist in Guangdon. "In China, everything is fake, and if there's a profit in pharmaceuticals, then someone's going to fake them too."

But perhaps international scrutiny of this problem will prompt swift reforms in how clinical trials will be conducted and inspected in the future in China.
 
Additional sources: Radio Free Asia, Science Alert
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 24, 2020
Cancer
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
NOV 24, 2020
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
Did you know sleeping is great? Apparently, getting a full eight hours every night can make you look fabulous and solve ...
DEC 03, 2020
Clinical & Molecular DX
Spit Contains Concussion Clues
DEC 03, 2020
Spit Contains Concussion Clues
Drowsiness, confusion, headaches, and sensitivity to light — it’s sometimes hard for doctors to spot the sig ...
DEC 14, 2020
Clinical & Molecular DX
STR Genotyping for Human Sample Identification
DEC 14, 2020
STR Genotyping for Human Sample Identification
Human sample identification is an essential element of many research projects employing human cells, tissues, or mixture ...
DEC 30, 2020
Clinical & Molecular DX
Of Mice and Men: Deep Learning Transforms Diagnostics
DEC 30, 2020
Of Mice and Men: Deep Learning Transforms Diagnostics
Medical imaging technologies enable physicians to take a peek under the hood, capturing snapshots of the internal organs ...
DEC 29, 2020
Clinical & Molecular DX
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
DEC 29, 2020
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
The statistics are a real eye-opener: in the United States, one person dies every 36 seconds from cardiovascular disease ...
FEB 15, 2021
Clinical & Molecular DX
Asking Patients the Right Questions About Their Symptoms
FEB 15, 2021
Asking Patients the Right Questions About Their Symptoms
A patient is admitted to the hospital after experiencing chest pains. What are the right questions that hospital staff a ...
Loading Comments...